Heart Failure Comorbidities

Oliviana Geavlete, Andrew P Ambrosy, Alexandre Mebazaa, et al

Read time: 35m
Biomarkers in heart failure: What’s new, tried, and true?

Harriette Van Spall, James L Januzzi

Watch time: 17m

Razvan I Radu, Beth Davison, Sean P Collins, et al

Read time: 30m

Mai H Duong, Martha Gulati, Parag Goyal, et al

Read time: 31m 40s

Leo Gozdecki, Mark N Belkin

Read time: 10m
High‑Stakes CKM Heart Failure Decisions

Robert Mentz

Watch time: 7m 27s
Heart Failure: Mechanisms, Therapy and What We Still Get Wrong

Milton Packer

Watch time: 11m 32s
Heart Failure in the Cardio-Renal-Metabolic Patient: Front-Line Decisions

Debasish Banerjee

Watch time: 9m 42s

Athena Adeli, Revathy Sampath-Kumar, Anne Wang, et al

Read time: 28m 20s

Michał Czapla, Christopher S Lee, Maria Jędrzejczyk, et al

Read time: 31m 40s
HFA 2026: Obesity and Natriuretic Peptides in Heart Failure — PORTHOS

Rui Baptista

Watch time: 8m 12s
HFA 2026: UF-CARE — Ultrafiltration in Type 2 Cardiorenal Syndrome

Guillaume Baudry

Watch time: 5m 55s

Andrew JS Coats, Stefan Anker

Ovidiu Chioncel, Alexandre Mebazaa, Sean P Collins, et al

Read time: 31m 40s
Ep 151: Cardiology's 2025 Year in Review with Dr Sukh Nijjer

Listen time: 1h 40m 44s
 Ep 146: The Heart Function Revolution: Why Prevention Matters

Listen time: 37m 49s

Bahira Shahim, Chris J Kapelios, Gianluigi Savarese, et al

Read time: 18m
EP 54: 5 Trials that will change your practice: Review of ESC 21 with Dr Purvi Parwani

Ankur Kalra, Purvi Parwani,

Listen time: 1h 17s
EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 5m 20s

Shubh K Patel, Hwee Teoh, Ahreni Saunthar, et al

Read time: 24m 34s
ESC 24 in Review with Dr Purvi Parwani

Listen time: 1h 6m 14s

Razvan I Radu, Beth Davison, Sean P Collins, et al

Read time: 30m

Fausto J Pinto, John Spertus, , et al

Watch time: 2s (19 videos)

Victoria Delgado, Laura Sanchis, Julia Grapsa, et al

About

Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.

Media

Biomarkers in heart failure: What’s new, tried, and true?

Harriette Van Spall, James L Januzzi

Watch time: 17m

Broadcast

Heart Failure
e-SPACE HF 2024 – Day Two

Clara Saldarriaga, Gianluigi Savarese, Javed Butler

Broadcast

Heart Failure
e-SPACE HF 2024 – Day One

Clara Saldarriaga, Gianluigi Savarese, Javed Butler

Stefan Anker, Giuseppe Rosano, Javier de Juan Bagudá, et al

Watch time: 15h 45m 20s (18 videos)

Broadcast

Guidelines & Statements

Heart Failure
Guideline Controversies

Watch time: 3h 27m 5s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: The HEART-FID Study

Robert Mentz

Watch time: 3m 59s
HFA 23: DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF

Domingo Figal

Watch time: 8m 47s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s
HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall

Watch time: 5m 48s

Broadcast

Guidelines & Statements

Heart Failure
e-SPACE HF 2023 – Day Two

William T Abraham, Marianna Adamo, Stefan Anker , et al

Broadcast

Heart Failure
e-SPACE HF 2023 – Day One

William T Abraham, Marianna Adamo, Stefan Anker , et al

Media

Biomarkers in heart failure: What’s new, tried, and true?

Harriette Van Spall, James L Januzzi

Watch time: 17m
High‑Stakes CKM Heart Failure Decisions

Robert Mentz

Watch time: 7m 27s
Heart Failure in the Cardio-Renal-Metabolic Patient: Front-Line Decisions

Debasish Banerjee

Watch time: 9m 42s
Heart Failure: Mechanisms, Therapy and What We Still Get Wrong

Milton Packer

Watch time: 11m 32s
HFA 2026: UF-CARE — Ultrafiltration in Type 2 Cardiorenal Syndrome

Guillaume Baudry

Watch time: 5m 55s
HFA 2026: Obesity and Natriuretic Peptides in Heart Failure — PORTHOS

Rui Baptista

Watch time: 8m 12s

Broadcast

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

ACC 26: SURPASS-CVOT - Tirzepatide vs Dulaglutide in T2D

Steven E Nissen

Watch time: 4m 47s

Javed Butler, Dinesh Khullar, John JV McMurray, et al

Watch time: 59m 13s (5 videos)
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s

Articles

Impact of Atrial Septal Defect on Hemodynamics

Saumil R Shah

,

Sergio Waxman

,

William H Gaasch

,

Citation:

US Cardiology Review 2017;11(2):72–4.

DOI:

https://doi.org/10.15420/ucs.2017:9:2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 37
  • Citations: 5

Cardiac Atrophy and Heart Failure In Cancer

Mark Sweeney

,

Angela Yiu

,

Alexander Lyon

,

Citation:

Cardiac Failure Review 2017;3(1):62–5

DOI:

https://doi.org/10.15420/cfr.2017:3:2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 8
  • Citations: 31

Treating Acute Heart Failure with Chronic Obstructive Pulmonary Disease

Jelena Celutkiene

,

Mindaugas Balčiūnas

,

Denis Kablučko

,

Liucija Vaitkevičiūtė

,

Jelena Blaščiuk

,

Edvardas Danila

,

Citation:

Cardiac Failure Review 3(1):56–61.

DOI:

https://doi.org/10.15420/cfr.2016:23:2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 34
  • Citations: 28

Cancer and Heart Failure: Understanding the Intersection

Carine E Hamo

,

Michelle W Bloom

,

Citation:

Cardiac Failure Review 2017;3(1):66–70.

DOI:

https://doi.org/10.15420/cfr.2016:24:2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 26
  • Citations: 13